E-LIB Suche - Ergebnisse für: De la Fouchardière, Christelle

1

Atezolizumab plus modified docetaxel, cisplatin, and fluoro..:

Kim, Stefano ; Ghiringhelli, Francois ; de la Fouchardière, Christelle...
The Lancet Oncology. 25 (2024) 4 - p. 518-528 , 2024

Link: https://doi.org/10.1016/..

2

Biliary tract cancers: French national clinical practice gu..:

Roth, Gael S. ; Verlingue, Loic ; Sarabi, Matthieu...
European Journal of Cancer. 202 (2024) - p. 114000 , 2024

Link: https://doi.org/10.1016/..

3

Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ..:

Botsen, Damien ; Chabaud, Sylvie ; Perrier, Hervé...
Digestive and Liver Disease. 56 (2024) 8 - p. 1281-1287 , 2024

Link: https://doi.org/10.1016/..

4

Triplet chemotherapy plus cetuximab as first-line treatment..:

Samalin, Emmanuelle ; Mazard, Thibault ; Assenat, Eric...
Digestive and Liver Disease. 56 (2024) 8 - p. 1375-1381 , 2024

Link: https://doi.org/10.1016/..

5

Safety and efficacy of nintedanib as second-line therapy fo..:

Leboulleux, Sophie ; Kapiteijn, Ellen ; Litière, Saskia...
Frontiers in Endocrinology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

6

Sunitinib for metastatic progressive phaeochromocytomas and..:

Baudin, Eric ; Goichot, Bernard ; Berruti, Alfredo...
The Lancet. 403 (2024) 10431 - p. 1061-1070 , 2024

Link: https://doi.org/10.1016/..

7

A multicenter study evaluating efficacy of immune checkpoin..:

Moreau, Mathilde ; Alouani, Emily ; Flecchia, Clémence...
European Journal of Cancer. 202 (2024) - p. 114033 , 2024

Link: https://doi.org/10.1016/..

8

A multicenter study evaluating efficacy of immune checkpoin..:

Moreau, Mathilde ; Alouani, Emily ; Flecchia, Clémence...
uri/info:doi/10.1016/j.ejca.2024.114033. , 2024

Link: http://hdl.handle.net/20..

9

Pathogenic alterations in PIK3CA and KMT2C are frequent and..:

Hamza, Abderaouf ; Masliah-Planchon, Julien ; Neuzillet, Cindy...
info:eu-repo/semantics/altIdentifier/doi/10.1002/ijc.34781. , 2024

Link: https://hal.science/hal-..

10

Biliary tract cancers: French national clinical practice gu..:

Roth, Gael S ; Verlingue, Loic ; Sarabi, Matthieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2024.114000. , 2024

Link: https://hal.science/hal-..

11

Table_1_Safety and efficacy of nintedanib as second-line th..:

Sophie Leboulleux ; Ellen Kapiteijn ; Saskia Litière...
doi:10.3389/fendo.2024.1403687.s002. , 2024

Link: https://doi.org/10.3389/..

12

Table_1_Safety and efficacy of nintedanib as second-line th..:

Sophie Leboulleux ; Ellen Kapiteijn ; Saskia Litière...
doi:10.3389/fendo.2024.1403687.s002. , 2024

Link: https://doi.org/10.3389/..

13

Improved guidance is needed to optimise diagnostics and tre..:

de la Fouchardière, Christelle ; Fugazzola, Laura ; Locati, Laura D...
https://pure.eur.nl/en/publications/a730c59f-86ec-40f6-8305-533b752b1dfb. , 2024

Link: https://pure.eur.nl/en/p..

14

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetux..:

Boige, Valérie ; Blons, Hélène ; Francois, Eric...
10.1001/jamanetworkopen.2023.33533. , 2024

Link: https://hdl.handle.net/2..

15

Biliary tract cancers: French national clinical practice gu..:

Roth, Gael S ; Verlingue, Loic ; Sarabi, Matthieu...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2024.114000. , 2024

Link: https://hal.science/hal-..